231 related articles for article (PubMed ID: 17637014)
41. Considerations for application of biopharmaceutics classification system in chicken: Exemplified by seven drugs classification.
Liu Y; Li X; Zhang Y; Huang J; Wu Y; Wang L
J Vet Pharmacol Ther; 2020 Mar; 43(2):179-188. PubMed ID: 32039497
[TBL] [Abstract][Full Text] [Related]
42. Biopharmaceutics classification and intestinal absorption of chikusetsusaponin IVa.
Zhang W; Liu H; Liu C
Biopharm Drug Dispos; 2019 Sep; 40(8):276-281. PubMed ID: 31294470
[TBL] [Abstract][Full Text] [Related]
43. Compound mixtures in Caco-2 cell permeability screens as a means to increase screening capacity.
Tannergren C; Langguth P; Hoffmann KJ
Pharmazie; 2001 Apr; 56(4):337-42. PubMed ID: 11338677
[TBL] [Abstract][Full Text] [Related]
44. Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration.
Wang W; Sasaki H; Chien DS; Lee VH
Curr Eye Res; 1991 Jun; 10(6):571-9. PubMed ID: 1680041
[TBL] [Abstract][Full Text] [Related]
45. Biopharmaceutics classification evaluation for paris saponin VII.
Zhang X; Sun Y; Cheng Y; Ye WL; Zhang BL; Mei QB; Zhou SY
Chin J Nat Med; 2020 Sep; 18(9):714-720. PubMed ID: 32928515
[TBL] [Abstract][Full Text] [Related]
46. Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers.
Saha P; Kou JH
Eur J Pharm Biopharm; 2000 Nov; 50(3):403-11. PubMed ID: 11072198
[TBL] [Abstract][Full Text] [Related]
47. Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats.
Li H; Dong L; Liu Y; Wang G; Wang G; Qiao Y
Int J Pharm; 2014 May; 466(1-2):133-8. PubMed ID: 24607203
[TBL] [Abstract][Full Text] [Related]
48. Current and evolving approaches for improving the oral permeability of BCS Class III or analogous molecules.
Dave VS; Gupta D; Yu M; Nguyen P; Varghese Gupta S
Drug Dev Ind Pharm; 2017 Feb; 43(2):177-189. PubMed ID: 27998192
[TBL] [Abstract][Full Text] [Related]
49. Artificial Lipid Membrane Permeability Method for Predicting Intestinal Drug Transport: Probing the Determining Step in the Oral Absorption of Sulfadiazine; Influence of the Formation of Binary and Ternary Complexes with Cyclodextrins.
Delrivo A; Aloisio C; Longhi MR; Granero G
AAPS PharmSciTech; 2018 Apr; 19(3):1437-1447. PubMed ID: 29450829
[TBL] [Abstract][Full Text] [Related]
50. Biopharmaceutics classification and intestinal absorption study of apigenin.
Zhang J; Liu D; Huang Y; Gao Y; Qian S
Int J Pharm; 2012 Oct; 436(1-2):311-7. PubMed ID: 22796171
[TBL] [Abstract][Full Text] [Related]
51. Quantitative structure-retention and retention-activity relationships of beta-blocking agents by micellar liquid chromatography.
Detroyer A; Vander Heyden Y; Carda-Broch S; García-Alvarez-Coque MC; Massart DL
J Chromatogr A; 2001 Apr; 912(2):211-21. PubMed ID: 11330791
[TBL] [Abstract][Full Text] [Related]
52. Toward an increased understanding of the barriers to colonic drug absorption in humans: implications for early controlled release candidate assessment.
Tannergren C; Bergendal A; Lennernäs H; Abrahamsson B
Mol Pharm; 2009; 6(1):60-73. PubMed ID: 19183105
[TBL] [Abstract][Full Text] [Related]
53. Integrating theoretical and experimental permeability estimations for provisional biopharmaceutical classification: Application to the WHO essential medicines.
Cabrera-Pérez MÁ; Pham-The H; Cervera MF; Hernández-Armengol R; Miranda-Pérez de Alejo C; Brito-Ferrer Y
Biopharm Drug Dispos; 2018 Jul; 39(7):354-368. PubMed ID: 30021059
[TBL] [Abstract][Full Text] [Related]
54. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification.
Kasim NA; Whitehouse M; Ramachandran C; Bermejo M; Lennernäs H; Hussain AS; Junginger HE; Stavchansky SA; Midha KK; Shah VP; Amidon GL
Mol Pharm; 2004 Jan; 1(1):85-96. PubMed ID: 15832504
[TBL] [Abstract][Full Text] [Related]
55. Biowaiver or Bioequivalence: Ambiguity in Sildenafil Citrate BCS Classification.
Miranda C; Pérez-Rodríguez Z; Hernández-Armengol R; Quiñones-García Y; Betancourt-Purón T; Cabrera-Pérez MÁ
AAPS PharmSciTech; 2018 May; 19(4):1693-1698. PubMed ID: 29532425
[TBL] [Abstract][Full Text] [Related]
56. The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.
Benet LZ
J Pharm Sci; 2013 Jan; 102(1):34-42. PubMed ID: 23147500
[TBL] [Abstract][Full Text] [Related]
57. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
[TBL] [Abstract][Full Text] [Related]
58. Considerations for a Pediatric Biopharmaceutics Classification System (BCS): application to five drugs.
Gandhi SV; Rodriguez W; Khan M; Polli JE
AAPS PharmSciTech; 2014 Jun; 15(3):601-11. PubMed ID: 24557773
[TBL] [Abstract][Full Text] [Related]
59. [Research on attributes of biopharmaceutics classification system for Chinese materia medica of baicalein in Gegen Qinlian Decoction environment].
Liu Y; Yang L; Zhang X; Cheng YR; Gong YT; Dong L
Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3653-3661. PubMed ID: 31602937
[TBL] [Abstract][Full Text] [Related]
60. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
